Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sobetirome (IACS-010759) 是一种甲状腺激素受体 β (TRβ) 激动剂,能够选择性的结合到TRβ-1(EC50:0.16 μM)。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 398 | 现货 | ||
2 mg | ¥ 563 | 现货 | ||
5 mg | ¥ 898 | 现货 | ||
10 mg | ¥ 1,370 | 现货 | ||
25 mg | ¥ 2,810 | 现货 | ||
50 mg | ¥ 4,170 | 现货 | ||
100 mg | ¥ 5,930 | 现货 | ||
200 mg | ¥ 8,230 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 945 | 现货 |
产品描述 | Sobetirome (IACS-010759) is a selective agonist of thyroid hormone receptor β (TRβ) and binds selectively to TRβ-1 (EC50: 0.16 μM). |
靶点活性 | TRα 1:0.58 μM (EC50), TRβ 1:0.16 μM (EC50) |
体外活性 | GC-1 was designed to bind selectively to TRβ (EC50: 0.58 μM for TRα-1, 0.16 μM for TRβ-1) [1]. The thyromimetic agent GC-1 induces hepatocyte proliferation via Wnt/β-catenin signaling and may promote regeneration in both acute and chronic liver insufficiencies [2]. |
体内活性 | Four weeks following injection, mice were fed 5 mg/kg GC-1 or basal diet for 10 or 21 days. Treatment with GC-1 for 10 or 21 days led to a significant reduction in tumor burden [2]. GC-1 treatment reduced serum cholesterol levels by 25% and serum triglycerides by 75% in chow-fed mice and also attenuated diet-induced hypercholesterolemia [3]. GC-1 (50 or 100 mug/100 g body weight) strongly stimulates rat hepatocyte proliferation in the absence of tissue injury. GC-1 also induced massive pancreatic cell proliferation [4]. |
动物实验 | Briefly, 20 μg of a pT3-EF5α-hMet-V5 and pT3-EF5α-S45Y-β-catenin-Myc combination along with the transposase in a ratio of 25:1 were diluted in 2 mL of normal saline (0.9% NaCl), filtered through a 0.22-μm filter, and injected into the lateral tail vein of 23 FVB mice that were around 6 weeks old, in 5 to 7 seconds. These mice are referred henceforth as hMet-mutant-β-catenin mice. Four weeks after injection, hMet-mutant-β-catenin mice were randomized into two groups. One group was kept on a basal diet (n = 12), and another group was switched to a GC-1–supplemented diet (5 mg/kg of diet) (n = 11). Animals on control diet were sacrificed at either 21 days (n = 8) or 10 days (n = 4) after initiation of the diet. Similarly, animals on the GC-1 diet were sacrificed at either 21 days (n = 7) or 10 days (n = 4) after initiation of the diet. The animals were given access to food and water ad libitum with a 12-hour light/dark daily cycle. One intraperitoneal injection of bromodeoxyuridine (BrdU) was performed on day 9 during 10 days of GC-1 or basal diet treatment, and livers were harvested 24 hours later [2]. |
别名 | IACS-010759, QRX-431 |
分子量 | 328.4 |
分子式 | C20H24O4 |
CAS No. | 211110-63-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (91.4 mM)
Ethanol: 30 mg/mL
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.0451 mL | 15.2253 mL | 30.4507 mL | 76.1267 mL |
5 mM | 0.609 mL | 3.0451 mL | 6.0901 mL | 15.2253 mL | |
10 mM | 0.3045 mL | 1.5225 mL | 3.0451 mL | 7.6127 mL | |
20 mM | 0.1523 mL | 0.7613 mL | 1.5225 mL | 3.8063 mL | |
50 mM | 0.0609 mL | 0.3045 mL | 0.609 mL | 1.5225 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Sobetirome 211110-63-3 Endocrinology/Hormones Thyroid hormone receptor(THR) QRX431 Inhibitor IACS010759 IACS-010759 GC1 inhibit QRX-431 IACS 010759 Thyroid Hormone Receptor QRX 431 GC-1 GC 1 THR inhibitor